Lymphoma Flashcards

1
Q

Cutaneous B cell lymphomas are lymphomas whose primary site is in the skin

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

B cell lymphomas make up a minority of NHLs whose primary site is in the skin

A

False, majority

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are poor prognostic factors of B cell lymphoma

A

Multifocal disease,
High serum level of LDH
Value of staging tumour burden in primary cutaneous MZL and primary cutaneous FCL has not been shown to have an impact on prognosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Solitary and grouped pink to plum coloured papules, plaques or tumours — aka “Crosti’s lymphoma”

A

True - primary cutaneous follicle centre lymphoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Primary cutaneous follicle centre lymphoma has recurrences up to 50% and commonly disseminates to LN or internal organs

A

False- Rarely disseminates

Recurrence rate correct

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Nodular and diffuse infiltrates occur in parts of the dermis with PCFCL

A

False - in the entire dermis, deeply extending to fat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

PCFCL epidermis usually involved on histo

A

False , usually spared

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

IHC of PCFCL

A

BCl-6 positive, CD20, CD79a, PAX-5 all positive

NEGATIVE CD5, CD43, BCl-2 —> this is a major difference to follicular lymphomas arising fro WITHIN lymph nodes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Prognosis excellent , LN/organ involvement rare w cutaneous marginal zone B cell lymphoma

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

CMZBCL can be strongly associated with scabies

A

False - has been linked with Borrelia and can occur in areas affected by ACRODERMATITIS chronica atrophicans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Trisomy 3 and 18 protect against CMZBCL

A

False- predispose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Resolution of cutaneous marginal zone B cell lymphoma can result in anetoderma

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Cutaneous marginal zone B cell lymphoma often very tender

A

False - usually asymptomatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

CMZBCL often ulcerate

A

False - rarely

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

IHC of CMZBCL

A

CD20, CD79a, BCl-2 positive,

NEG BCl-6, CD5, CD10

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Primary cutaneous large B cell lymphoma occurs exclusively in elderly patients, predominantly men

A

False - predominantly women

17
Q

Primary cutaneous large B cell lymphoma, leg type IHC

A

CD20, CD79a, PAX-5, BCl-2 , MUM-1 , FOXP1

18
Q

CDKN2A mutations confer a better prognosis with PCLBCL

A

False -worse

19
Q

Intravascular diffuse large B cell lymphoma Often Present as macular erythematous and violaceous patches and plaques on trunk and thighs

A

False - indurated

20
Q

Intravascular diffuse large B cell lymphoma IHC

A

Positive for BCl-2, MUM-1 , FOX-P1

21
Q

Sezary syndrome triad

A

Circulating neoplastic T cells >1000/mcl
Erythroderma
With/without associated lymphadenopathy

22
Q

Transformed MF is characterised by moprphological change of small to medium sized atypical T lymphocytes to a large cell variant

A

True

23
Q

Need >75% of neoplastic T cell 4 x size of normal lymphocytes to diagnose large cell transformation

A

False, >25%

24
Q

Negative prognostic factors for MF

A
MAFIA BEL large sezary clone 30-
Male
Age
Folliculotropic variant
Initial treatment poor response
Advanced skin burden (T score)

B2 microglobulin
Eosinophilia
LDH

Large cell transformation
Sezary cell count high
Peripheral blood T cell clone detectable
CD30 neg

25
Q

Extracorporeal plasmapharesis is helpful for Sezary B0-B2

A

True

26
Q

Imiquimod is a treatment option for MF

A

true - 5% mon to fri for 12 weeks

27
Q

Alemtuzumab is an antiCD30 drug

A

False anti-CD52

28
Q

Folliculotropic MF displays overt epidermotropism

A

False - folliculotropic instead of epidermotropic

29
Q

Long term follow up is necessary for LyP as risk of progression to more aggressive lymphoma eg. P C-ACL, MF or Hodgkin in 20%

A

False <5%

30
Q

LyP spontaneously disappear over 3-8 weeks

A

True

31
Q

SC panniculitis like T cell lymphoma occurs in the trunk>extremities

A

False vice versa